GANX (STOCKS)
Gain Therapeutics, Inc. Common Stock
$1.330000
+0.010000 (+0.76%)
Prev close: $1.320000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gene C. Mack
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $57.61M
- Employees
- 25
- P/E (TTM)
- -2.61
- P/B (TTM)
- 5.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.11 | $-0.14 | +0.0348 | +24.03% |
|
Mar 2026 (Q1)
|
$-0.13 | $-0.14 | +0.0103 | +7.34% |
|
Dec 2025 (Q4)
|
$-0.11 | $-0.15 | +0.0379 | +25.63% |
|
Sep 2025 (Q3)
|
$-0.15 | $-0.15 | +0.0030 | +1.96% |